The Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant markups. Justices Vikram Nath and SVN Bhatti criticized pharma companies for neglecting the struggles of ordinary people. They urged the government to consider a uniform pricing rule that limits maximum retail prices. The court highlighted the burden on taxpayers due to inflated medical expenses reimbursed under public health schemes.
RSS News
Economic times
0 thoughts on “SC seeks 16% MRP cap on medicines, flags huge cancer drug markups”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- Pralay: Kalyani Priyadarshan shifts to Mumbai, trains for Ranveer Singh starrer
- Shanoo post sparks debate: Casting director’s ‘talent’ note divides actors
- Aishwarya Rai Bachchan tells paps to get together for a group photo
- Rajinikanth surprises fans by arriving at ‘Dharmam’ shoot in an auto-rickshaw
- Centre agrees to procure sunflower, green gram, and soyabean crops at MSP in Karnataka
